Alfred Sze-Lok Cheng

6PUBLICATIONS
133CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersHaematological tumoursCell and nuclear divisionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2026
EpiATLAS - a reference for human epigenomic research.

|Dec 13, 2025
Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential.

Clooney C Y Cheng, Ming Fung Cheung, Ah Young Lee

|Jul 14, 2025
FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.

Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang

|May 14, 2025
Tumor Suppressor Genes with Segmental Duplications Are Prone to Somatic Deletions and Structural Variations.

Ziheng Huang, Lin Zhang, Huarong Chen

|Apr 08, 2021
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma.

Weiqin Yang, Yu Feng, Jingying Zhou

|Feb 21, 2019
New guidelines for DNA methylome studies regarding 5-hydroxymethylcytosine for understanding transcriptional regulation.

Le Li, Yuwei Gao, Qiong Wu

Pageof 1

Frequent Collaborators

3 joint publications

Weiqin Yang

3 joint publications

Kevin Y Yip

3 joint publications

Ka-Fai To

2 joint publications

Clooney Cheuk Yin Cheng